Drug Information Journal

Show Articles
Journal Properties
  • Continued as
    Therapeutic Innovation and Regulatory Science
  • Language
    English
  • Number of Articles
    3,415
  • Abbreviation
    Drug Inf J
  • ISSN
    0092-8615
  • Main Publisher
    Drug Information Association
  • Publisher
    Springer Science and Business Media LLC
  • Indian UGC
  • DOAJ (latest)
Description
Drug Information Journal is designed to address issues associated with drug use. This journal covers a wide range of topics, including drug safety, drug regulation, risk management, and pharmaceutical policy. It provides insights into the communication and dissemination of drug-related information to healthcare professionals and the public. Featured content includes original research articles, reviews, and perspectives that explore drug development, regulatory affairs, and risk mitigation strategies. It also addresses aspects of drug utilization, pharmacovigilance, and patient education. Indexed in databases like Scopus and Embase, it serves as a key resource for pharmaceutical scientists, regulatory agencies, and healthcare providers. The journal emphasizes the importance of evidence-based drug information to improve patient safety and outcomes. It seeks to contribute to the effective communication and management of drug-related risks. Its open-access nature ensures that valuable drug information is readily available, promoting global collaboration and informing best practices.